||This study will be conducted in approximately 1000 investigational centres in approximately 40 count . . .
||12 Feb 2015 10:35:30
| ||A multicenter, open-label, randomized, event-driven study to assess efficacy, safety and pharmacokin . . .
||This is a prospective, multicenter, open-label, randomized, controlled, parallel group, group-sequen . . .
||19 Apr 2017 09:22:26
| ||A Phase III, Randomized, Open-Label, Controlled, Multi-Center, Global Study of First-Line Durvalumab . . .
||This is a randomized, open-label, controlled, multi-center, global Phase III study to determine the . . .
||10 Jan 2019 05:37:35